[1]
Nakagawa Y, Nishikimi T, Kuwahara K. Atrial and brain natriuretic peptides: Hormones secreted from the heart. Peptides. 2019 Jan:111():18-25. doi: 10.1016/j.peptides.2018.05.012. Epub 2018 May 31
[PubMed PMID: 29859763]
[2]
de Bold AJ, Borenstein HB, Veress AT, Sonnenberg H. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life sciences. 1981 Jan 5:28(1):89-94
[PubMed PMID: 7219045]
[3]
Cannone V, Cabassi A, Volpi R, Burnett JC, Jr. Atrial Natriuretic Peptide: A Molecular Target of Novel Therapeutic Approaches to Cardio-Metabolic Disease. International journal of molecular sciences. 2019 Jul 2:20(13):. doi: 10.3390/ijms20133265. Epub 2019 Jul 2
[PubMed PMID: 31269783]
[4]
Volpe M, Carnovali M, Mastromarino V. The natriuretic peptides system in the pathophysiology of heart failure: from molecular basis to treatment. Clinical science (London, England : 1979). 2016 Jan:130(2):57-77. doi: 10.1042/CS20150469. Epub
[PubMed PMID: 26637405]
[5]
Martel G, Hamet P, Tremblay J. Central role of guanylyl cyclase in natriuretic peptide signaling in hypertension and metabolic syndrome. Molecular and cellular biochemistry. 2010 Jan:334(1-2):53-65. doi: 10.1007/s11010-009-0326-8. Epub 2009 Nov 25
[PubMed PMID: 19937369]
[6]
Lafontan M, Moro C, Berlan M, Crampes F, Sengenes C, Galitzky J. Control of lipolysis by natriuretic peptides and cyclic GMP. Trends in endocrinology and metabolism: TEM. 2008 May-Jun:19(4):130-7. doi: 10.1016/j.tem.2007.11.006. Epub 2008 Mar 11
[PubMed PMID: 18337116]
[7]
Engeli S, Birkenfeld AL, Badin PM, Bourlier V, Louche K, Viguerie N, Thalamas C, Montastier E, Larrouy D, Harant I, de Glisezinski I, Lieske S, Reinke J, Beckmann B, Langin D, Jordan J, Moro C. Natriuretic peptides enhance the oxidative capacity of human skeletal muscle. The Journal of clinical investigation. 2012 Dec:122(12):4675-9. doi: 10.1172/JCI64526. Epub 2012 Nov 1
[PubMed PMID: 23114600]
[8]
Tsukamoto O, Fujita M, Kato M, Yamazaki S, Asano Y, Ogai A, Okazaki H, Asai M, Nagamachi Y, Maeda N, Shintani Y, Minamino T, Asakura M, Kishimoto I, Funahashi T, Tomoike H, Kitakaze M. Natriuretic peptides enhance the production of adiponectin in human adipocytes and in patients with chronic heart failure. Journal of the American College of Cardiology. 2009 Jun 2:53(22):2070-7. doi: 10.1016/j.jacc.2009.02.038. Epub
[PubMed PMID: 19477358]
[9]
Birkenfeld AL, Boschmann M, Engeli S, Moro C, Arafat AM, Luft FC, Jordan J. Atrial natriuretic peptide and adiponectin interactions in man. PloS one. 2012:7(8):e43238. doi: 10.1371/journal.pone.0043238. Epub 2012 Aug 16
[PubMed PMID: 22916229]
[10]
Maeda N, Shimomura I, Kishida K, Nishizawa H, Matsuda M, Nagaretani H, Furuyama N, Kondo H, Takahashi M, Arita Y, Komuro R, Ouchi N, Kihara S, Tochino Y, Okutomi K, Horie M, Takeda S, Aoyama T, Funahashi T, Matsuzawa Y. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nature medicine. 2002 Jul:8(7):731-7
[PubMed PMID: 12068289]
[11]
Shibata R, Ouchi N, Ito M, Kihara S, Shiojima I, Pimentel DR, Kumada M, Sato K, Schiekofer S, Ohashi K, Funahashi T, Colucci WS, Walsh K. Adiponectin-mediated modulation of hypertrophic signals in the heart. Nature medicine. 2004 Dec:10(12):1384-9
[PubMed PMID: 15558058]
[12]
Shibata R, Sato K, Pimentel DR, Takemura Y, Kihara S, Ohashi K, Funahashi T, Ouchi N, Walsh K. Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms. Nature medicine. 2005 Oct:11(10):1096-103
[PubMed PMID: 16155579]
[13]
Costello-Boerrigter LC, Burnett JC Jr. A new role for the natriuretic peptides: metabolic regulators of the adipocyte. Journal of the American College of Cardiology. 2009 Jun 2:53(22):2078-9. doi: 10.1016/j.jacc.2009.02.037. Epub
[PubMed PMID: 19477359]
[14]
Fu S, Ping P, Wang F, Luo L. Synthesis, secretion, function, metabolism and application of natriuretic peptides in heart failure. Journal of biological engineering. 2018:12():2. doi: 10.1186/s13036-017-0093-0. Epub 2018 Jan 12
[PubMed PMID: 29344085]
[15]
Rubattu S, Bigatti G, Evangelista A, Lanzani C, Stanzione R, Zagato L, Manunta P, Marchitti S, Venturelli V, Bianchi G, Volpe M, Stella P. Association of atrial natriuretic peptide and type a natriuretic peptide receptor gene polymorphisms with left ventricular mass in human essential hypertension. Journal of the American College of Cardiology. 2006 Aug 1:48(3):499-505
[PubMed PMID: 16875975]
[16]
Jujić A, Leosdottir M, Östling G, Gudmundsson P, Nilsson PM, Melander O, Magnusson M. A genetic variant of the atrial natriuretic peptide gene is associated with left ventricular hypertrophy in a non-diabetic population--the Malmö preventive project study. BMC medical genetics. 2013 Jun 24:14():64. doi: 10.1186/1471-2350-14-64. Epub 2013 Jun 24
[PubMed PMID: 23799939]
[17]
Cannone V, Boerrigter G, Cataliotti A, Costello-Boerrigter LC, Olson TM, McKie PM, Heublein DM, Lahr BD, Bailey KR, Averna M, Redfield MM, Rodeheffer RJ, Burnett JC Jr. A genetic variant of the atrial natriuretic peptide gene is associated with cardiometabolic protection in the general community. Journal of the American College of Cardiology. 2011 Aug 2:58(6):629-36. doi: 10.1016/j.jacc.2011.05.011. Epub
[PubMed PMID: 21798427]
[18]
Cannone V, Cefalu' AB, Noto D, Scott CG, Bailey KR, Cavera G, Pagano M, Sapienza M, Averna MR, Burnett JC Jr. The atrial natriuretic peptide genetic variant rs5068 is associated with a favorable cardiometabolic phenotype in a Mediterranean population. Diabetes care. 2013 Sep:36(9):2850-6. doi: 10.2337/dc12-2337. Epub 2013 May 1
[PubMed PMID: 23637347]
[19]
Arora P, Wu C, Khan AM, Bloch DB, Davis-Dusenbery BN, Ghorbani A, Spagnolli E, Martinez A, Ryan A, Tainsh LT, Kim S, Rong J, Huan T, Freedman JE, Levy D, Miller KK, Hata A, Del Monte F, Vandenwijngaert S, Swinnen M, Janssens S, Holmes TM, Buys ES, Bloch KD, Newton-Cheh C, Wang TJ. Atrial natriuretic peptide is negatively regulated by microRNA-425. The Journal of clinical investigation. 2013 Aug:123(8):3378-82. doi: 10.1172/JCI67383. Epub 2013 Jul 15
[PubMed PMID: 23867623]
[20]
Franco F, Dubois SK, Peshock RM, Shohet RV. Magnetic resonance imaging accurately estimates LV mass in a transgenic mouse model of cardiac hypertrophy. The American journal of physiology. 1998 Feb:274(2):H679-83. doi: 10.1152/ajpheart.1998.274.2.H679. Epub
[PubMed PMID: 9486274]
[21]
Nadar SK, Shaikh MM. Biomarkers in Routine Heart Failure Clinical Care. Cardiac failure review. 2019 Feb:5(1):50-56. doi: 10.15420/cfr.2018.27.2. Epub
[PubMed PMID: 30847246]
[22]
Mayo DD, Colletti JE, Kuo DC. Brain natriuretic peptide (BNP) testing in the emergency department. The Journal of emergency medicine. 2006 Aug:31(2):201-10
[PubMed PMID: 17044584]
[24]
McMurray JJ, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Solomon SD, Swedberg K, Zile MR, PARADIGM-HF Investigators and Committees. Angiotensin-neprilysin inhibition versus enalapril in heart failure. The New England journal of medicine. 2014 Sep 11:371(11):993-1004. doi: 10.1056/NEJMoa1409077. Epub 2014 Aug 30
[PubMed PMID: 25176015]
[25]
Velazquez EJ, Morrow DA, DeVore AD, Duffy CI, Ambrosy AP, McCague K, Rocha R, Braunwald E, PIONEER-HF Investigators. Angiotensin-Neprilysin Inhibition in Acute Decompensated Heart Failure. The New England journal of medicine. 2019 Feb 7:380(6):539-548. doi: 10.1056/NEJMoa1812851. Epub 2018 Nov 11
[PubMed PMID: 30415601]
[26]
Nougué H, Pezel T, Picard F, Sadoune M, Arrigo M, Beauvais F, Launay JM, Cohen-Solal A, Vodovar N, Logeart D. Effects of sacubitril/valsartan on neprilysin targets and the metabolism of natriuretic peptides in chronic heart failure: a mechanistic clinical study. European journal of heart failure. 2019 May:21(5):598-605. doi: 10.1002/ejhf.1342. Epub 2018 Dec 6
[PubMed PMID: 30520545]
[27]
Ibrahim NE, McCarthy CP, Shrestha S, Gaggin HK, Mukai R, Szymonifka J, Apple FS, Burnett JC Jr, Iyer S, Januzzi JL Jr. Effect of Neprilysin Inhibition on Various Natriuretic Peptide Assays. Journal of the American College of Cardiology. 2019 Mar 26:73(11):1273-1284. doi: 10.1016/j.jacc.2018.12.063. Epub
[PubMed PMID: 30898202]
[28]
Goodfriend TL, Calhoun DA. Resistant hypertension, obesity, sleep apnea, and aldosterone: theory and therapy. Hypertension (Dallas, Tex. : 1979). 2004 Mar:43(3):518-24
[PubMed PMID: 14732721]
[29]
John SW, Krege JH, Oliver PM, Hagaman JR, Hodgin JB, Pang SC, Flynn TG, Smithies O. Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension. Science (New York, N.Y.). 1995 Feb 3:267(5198):679-81
[PubMed PMID: 7839143]
[30]
Macheret F, Heublein D, Costello-Boerrigter LC, Boerrigter G, McKie P, Bellavia D, Mangiafico S, Ikeda Y, Bailey K, Scott CG, Sandberg S, Chen HH, Malatino L, Redfield MM, Rodeheffer R, Burnett J Jr, Cataliotti A. Human hypertension is characterized by a lack of activation of the antihypertensive cardiac hormones ANP and BNP. Journal of the American College of Cardiology. 2012 Oct 16:60(16):1558-65. doi: 10.1016/j.jacc.2012.05.049. Epub
[PubMed PMID: 23058313]
[31]
Buglioni A, Cannone V, Cataliotti A, Sangaralingham SJ, Heublein DM, Scott CG, Bailey KR, Rodeheffer RJ, Dessì-Fulgheri P, Sarzani R, Burnett JC Jr. Circulating aldosterone and natriuretic peptides in the general community: relationship to cardiorenal and metabolic disease. Hypertension (Dallas, Tex. : 1979). 2015 Jan:65(1):45-53. doi: 10.1161/HYPERTENSIONAHA.114.03936. Epub 2014 Nov 3
[PubMed PMID: 25368032]
[32]
Cannone V, Buglioni A, Sangaralingham SJ, Scott C, Bailey KR, Rodeheffer R, Redfield MM, Sarzani R, Burnett JC Jr. Aldosterone, Hypertension, and Antihypertensive Therapy: Insights From a General Population. Mayo Clinic proceedings. 2018 Aug:93(8):980-990. doi: 10.1016/j.mayocp.2018.05.027. Epub
[PubMed PMID: 30077215]
[33]
Saito Y. Roles of atrial natriuretic peptide and its therapeutic use. Journal of cardiology. 2010 Nov:56(3):262-70. doi: 10.1016/j.jjcc.2010.08.001. Epub 2010 Sep 29
[PubMed PMID: 20884176]
[34]
O'Connor CM, Starling RC, Hernandez AF, Armstrong PW, Dickstein K, Hasselblad V, Heizer GM, Komajda M, Massie BM, McMurray JJ, Nieminen MS, Reist CJ, Rouleau JL, Swedberg K, Adams KF Jr, Anker SD, Atar D, Battler A, Botero R, Bohidar NR, Butler J, Clausell N, Corbalán R, Costanzo MR, Dahlstrom U, Deckelbaum LI, Diaz R, Dunlap ME, Ezekowitz JA, Feldman D, Felker GM, Fonarow GC, Gennevois D, Gottlieb SS, Hill JA, Hollander JE, Howlett JG, Hudson MP, Kociol RD, Krum H, Laucevicius A, Levy WC, Méndez GF, Metra M, Mittal S, Oh BH, Pereira NL, Ponikowski P, Tang WH, Tanomsup S, Teerlink JR, Triposkiadis F, Troughton RW, Voors AA, Whellan DJ, Zannad F, Califf RM. Effect of nesiritide in patients with acute decompensated heart failure. The New England journal of medicine. 2011 Jul 7:365(1):32-43. doi: 10.1056/NEJMoa1100171. Epub
[PubMed PMID: 21732835]
[35]
Bordicchia M, Liu D, Amri EZ, Ailhaud G, Dessì-Fulgheri P, Zhang C, Takahashi N, Sarzani R, Collins S. Cardiac natriuretic peptides act via p38 MAPK to induce the brown fat thermogenic program in mouse and human adipocytes. The Journal of clinical investigation. 2012 Mar:122(3):1022-36. doi: 10.1172/JCI59701. Epub 2012 Feb 6
[PubMed PMID: 22307324]
[36]
Verboven K, Hansen D, Jocken JWE, Blaak EE. Natriuretic peptides in the control of lipid metabolism and insulin sensitivity. Obesity reviews : an official journal of the International Association for the Study of Obesity. 2017 Nov:18(11):1243-1259. doi: 10.1111/obr.12598. Epub 2017 Sep 12
[PubMed PMID: 28901677]
[37]
Magnusson M, Jujic A, Hedblad B, Engström G, Persson M, Struck J, Morgenthaler NG, Nilsson P, Newton-Cheh C, Wang TJ, Melander O. Low plasma level of atrial natriuretic peptide predicts development of diabetes: the prospective Malmo Diet and Cancer study. The Journal of clinical endocrinology and metabolism. 2012 Feb:97(2):638-45. doi: 10.1210/jc.2011-2425. Epub 2011 Nov 23
[PubMed PMID: 22112816]